125 related articles for article (PubMed ID: 31722837)
21. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
Katzmann JA; Clark R; Kyle RA; Larson DR; Therneau TM; Melton LJ; Benson JT; Colby CL; Dispenzieri A; Landgren O; Kumar S; Bradwell AR; Cerhan JR; Rajkumar SV
Leukemia; 2013 Jan; 27(1):208-12. PubMed ID: 22781594
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
23. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.
Nasr SH; Fidler ME; Said SM; Koepplin JW; Altamirano-Alonso JM; Leung N
Kidney Int; 2021 Jul; 100(1):155-170. PubMed ID: 33774084
[TBL] [Abstract][Full Text] [Related]
24. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression.
Andrade-Campos M; Murillo-Flórez I; García-Sanz R; Giraldo P
Clin Chem Lab Med; 2017 Aug; 55(10):1598-1604. PubMed ID: 28284031
[TBL] [Abstract][Full Text] [Related]
25. Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.
Sachchithanantham S; Berlanga O; Alvi A; Mahmood SA; Lachmann HJ; Gillmore JD; Hawkins PN; Harding S; Wechalekar AD
Br J Haematol; 2017 Nov; 179(4):575-585. PubMed ID: 28990174
[TBL] [Abstract][Full Text] [Related]
26. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
27. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
[TBL] [Abstract][Full Text] [Related]
28. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
[TBL] [Abstract][Full Text] [Related]
29. [The role of the assessment of heavy/light chain pairs of immunoglobulin in monoclonal gammopathies].
Ščudla V; Pika T; Minařík J
Vnitr Lek; 2015 Jan; 61(1):60-1, 63-71. PubMed ID: 25693618
[TBL] [Abstract][Full Text] [Related]
30. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
31. N-glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia.
Wang W; Xu X; Huang C; Gao C
J Clin Lab Anal; 2022 Feb; 36(2):e24201. PubMed ID: 34957618
[TBL] [Abstract][Full Text] [Related]
32. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.
Palladini G; Jaccard A; Milani P; Lavergne D; Foli A; Bender S; Lavatelli F; Bosoni T; Valentini V; Pirolini L; Ferraro G; Basset M; Russo F; Nuvolone M; Albertini R; Cogne M; Merlini G
Clin Chem Lab Med; 2017 Oct; 55(11):1734-1743. PubMed ID: 28343171
[TBL] [Abstract][Full Text] [Related]
33. Detection of leukemia markers using long-range surface plasmon waveguides functionalized with Protein G.
Krupin O; Wang C; Berini P
Lab Chip; 2015 Nov; 15(21):4156-65. PubMed ID: 26374150
[TBL] [Abstract][Full Text] [Related]
34. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
[TBL] [Abstract][Full Text] [Related]
35. Triclonal gammopathy in an extranodal non-Hodgkin lymphoma patient.
Tirelli A; Guastafierro S; Cava B; Lucivero G
Am J Hematol; 2003 Aug; 73(4):273-5. PubMed ID: 12879432
[TBL] [Abstract][Full Text] [Related]
36. Clonal restriction of platelet-associated anti-GPIIb/IIIa autoantibodies in patients with chronic ITP.
McMillan R; Lopez-Dee J; Bowditch R
Thromb Haemost; 2001 May; 85(5):821-3. PubMed ID: 11372674
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) - Benefit for Stratification of Multiple Myeloma?].
Ščudla V; Lochaman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Klin Onkol; 2015; 28(5):359-69. PubMed ID: 26480864
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
[TBL] [Abstract][Full Text] [Related]
39. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
[TBL] [Abstract][Full Text] [Related]
40. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
